Onderneming Viridian Therapeutics, Inc.
Aandelen
VRDN
US92790C1045
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
14,58 USD | +5,58% | +14,80% | -33,06% |
21/03 | VIRIDIAN THERAPEUTICS, INC. : B. Riley ontvangt een koopadvies | ZM |
28/02 | VIRIDIAN THERAPEUTICS, INC. : Wedbush ontvangt een koopadvies | ZM |
Vakgebied
Aantal werknemers: 94
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Monoclonal Antibody
100,0
%
| 2 | 100,0 % | 0 | 100,0 % | -82,28% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 | 100,0 % | 0 | 100,0 % | -82,28% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Mahoney
CEO | Chief Executive Officer | 53 | 30-10-23 |
Seth Harmon
DFI | Director of Finance/CFO | 45 | 01-05-23 |
Thomas Ciulla
CTO | Chief Tech/Sci/R&D Officer | 59 | 01-01-23 |
Thomas Beetham
COO | Chief Operating Officer | 55 | 30-10-23 |
Angela Sheen
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-20 |
Shan Wu
PRN | Corporate Officer/Principal | - | 30-10-23 |
Vahe Bedian
PRN | Corporate Officer/Principal | - | 28-10-20 |
Anthony Casciano
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Arlene Morris
BRD | Director/Board Member | 72 | 03-01-18 |
Tomas Kiselak
CHM | Chairman | 38 | 28-10-20 |
Stephen Mahoney
CEO | Chief Executive Officer | 53 | 30-10-23 |
Peter Harwin
BRD | Director/Board Member | 38 | 28-10-20 |
Jennifer Moses
BRD | Director/Board Member | 49 | 14-07-21 |
Sarah Gheuens
BRD | Director/Board Member | 45 | 25-09-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 172 435 | 0 | 0 | 92,69 % |
Aandeel B | 0 | 143 522 | 0 | 0 | |
Aandeel C | 1 | 63 822 468 | 59 159 235 ( 92,69 %) | 0 |
Bedrijfsgegevens
Viridian Therapeutics, Inc.
221 Crescent Street Suite 401
02453, Waltham
+
http://www.viridiantherapeutics.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-33,06% | 881 mln. | |
+26,28% | 42,68 mld. | |
-3,99% | 42,4 mld. | |
+45,32% | 40,04 mld. | |
-6,20% | 28,31 mld. | |
+6,36% | 24,94 mld. | |
-21,47% | 18,96 mld. | |
+27,58% | 12,3 mld. | |
-2,75% | 11,95 mld. | |
-2,02% | 11,55 mld. |
- Beurs
- Aandelen
- Koers VRDN
- Onderneming Viridian Therapeutics, Inc.